NeuPath Health (TSXV:NPTH) YoY EBITDA Growth : -25.00% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is NeuPath Health YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. NeuPath Health's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -25.00%.

NeuPath Health's EBITDA per Share for the three months ended in Mar. 2024 was C$0.01.

NeuPath Health YoY EBITDA Growth Historical Data

The historical data trend for NeuPath Health's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuPath Health YoY EBITDA Growth Chart

NeuPath Health Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

-2.94

145.71

-168.75

690.91

NeuPath Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															500.00	41.67	580.00	164.71	-25.00

NeuPath Health YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

NeuPath Health's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(0.065	-	-0.011)	/	\| -0.011 \|
=	690.91 %

NeuPath Health's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(0.009	-	0.012)	/	\| 0.012 \|
=	-25.00 %

NeuPath Health YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of NeuPath Health's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

NeuPath Health (TSXV:NPTH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NeuPath Health Inc (TSXV:NPTH) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

181 Bay Street, Suite 2100, Toronto, ON, CAN, M5J 2T3

Website

https://www.neupath.com

NeuPath Health Inc operates an end-to-end, integrated network of healthcare businesses. It utilizes research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by acute and chronic musculoskeletal conditions, including chronic pain, spinal injuries, sports-related injuries, and concussions. It operates an interdisciplinary network of medical clinics in Ontario and Alberta, in addition to an independent medical assessment business with a national network of healthcare providers. Its medical clinics provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports-related injuries, and concussions.

Executives

Grant Connelly	Senior Officer
Stephen Lemieux	Senior Officer

NeuPath Health (TSXV:NPTH) Headlines

No Headlines